17alpha bio

Patient-focused therapeutic development in the space of age-related diseases.

17alpha bio

Patient-focused therapeutic development in the space of age-related diseases.

With 17alpha bio, we are building a new life science company on the biology of one of the most impactful therapies for population health.

Christopher Shepard, CEO

We are unlocking the translational biology of an important biological node demonstrated in both preclinical and clinical studies to dictate the trajectory of age-related disease and healthspan.

17alpha bio is committed to innovation in a space that has been a backbone of therapy for a number of diseases.

Backed by Apollo Health Ventures.

Currently in research-stage.

Contact us: info@17alpha.bio